Physician profile
William D Hill
NPI 1659414662
$662.33
in general payments reported to CMS, 2019-2025
14 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $11.18 · 2021: $46.81 · 2022: $50.22 · 2023: $163 · 2024: $95.74 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142.55 | 2022-2025 | |
| Genentech USA, INC. | $102.77 | 2019-2025 | Vabysmo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $95.20 | 2023-2024 | Eylea Hd, Eylea |
| Sun Pharmaceutical Industries INC. | $46.05 | 2019-2025 | |
| Biotissue Holdings INC. | $43.51 | 2022-2025 | |
| Rxsight INC | $22.78 | 2023 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Bausch & Lomb Americas INC. | $19.90 | 2025 | Miebo, Xiidra |
| Mallinckrodt Hospital Products INC. | $18.65 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.54 | 2022 | |
| Aerie Pharmaceuticals, INC. | $16.19 | 2021 | |
| Alcon Vision LLC | $14.04 | 2023 | Total30 |
| Johnson & Johnson Surgical Vision, INC. | $11.97 | 2021 | |
| Allergan, INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.